ICSR and Aggregate Reporting Explained | Pharmacovigilance Reports GVP Module 6 Guide

Individual Case Safety Report | What does Aggregate Reporting Mean | Clinical Trial To Contact Us - https://links.careerinpharma.com/inquiry For further information click here - https://links.careerinpharma.com/profile Individual Case Safety Report | What does Aggregate Reporting Mean | Clinical Trial Understand the core concepts of pharmacovigilance reporting with this detailed explanation of Individual Case Safety Report and Aggregate Reports used in drug safety In this video you will learn what is ICSR how individual case safety reports are created and why they are important for identifying adverse drug reactions in clinical trials and post marketing surveillance We also explain aggregate reporting meaning and how cumulative safety data is used to evaluate benefit risk profile of a drug This includes key reports like PSUR PBRER and DSUR which are essential for regulatory submissions The video also covers GVP Module 6 guidelines timelines for ICSR reporting US FDA timelines and global regulatory requirements which are frequently asked in pharmacovigilance interview questions If you are preparing for pharmacovigilance interviews or want to understand drug safety reporting in a practical way this video will help you build strong fundamentals Video Timeline 01:26 ICSR and aggregate reports overview 01:52 GVP guidelines 03:05 GVP module 6 explained 03:48 ICSR timelines 05:43 US FDA timeline 07:35 Regulatory timelines 08:13 Aggregate reports explained 09:08 Purpose of aggregate reports 12:21 Conclusion #pharmacovigilance #icsr #aggregatereporting #drugsafety #careerinpharma #clinicalresearch